000 | 01029 a2200289 4500 | ||
---|---|---|---|
005 | 20250513142920.0 | ||
264 | 0 | _c19980522 | |
008 | 199805s 0 0 eng d | ||
022 | _a0009-9147 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLinder, M W | |
245 | 0 | 0 |
_aStandards of laboratory practice: antidepressant drug monitoring. National Academy of Clinical Biochemistry. _h[electronic resource] |
260 |
_bClinical chemistry _cMay 1998 |
||
300 |
_a1073-84 p. _bdigital |
||
500 | _aPublication Type: Guideline; Journal Article; Practice Guideline; Review | ||
650 | 0 | 4 |
_aAging _xmetabolism |
650 | 0 | 4 |
_aAntidepressive Agents _xadverse effects |
650 | 0 | 4 |
_aAntidepressive Agents, Tricyclic _xadverse effects |
650 | 0 | 4 |
_aDepression _xdrug therapy |
650 | 0 | 4 | _aDrug Interactions |
650 | 0 | 4 |
_aDrug Monitoring _xmethods |
650 | 0 | 4 |
_aDrug Overdose _xblood |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLithium _xadverse effects |
700 | 1 | _aKeck, P E | |
773 | 0 |
_tClinical chemistry _gvol. 44 _gno. 5 _gp. 1073-84 |
|
999 |
_c9557165 _d9557165 |